4

Back to all posts

Fedex Awards More Than $250,000 to Winners of the Annual Fedex Small Business Grant Contest
Dr. Ginger Johnson, RenoVō, Equine Regenerative Medicine, Stem Cell Therapy, Entrepreneurial Leadership
FedEx 2021 Grand Prize Small Business Grant Contest

MEMPHIS, Tenn.–(BUSINESS WIRE)–FedEx Corp. (NYSE: FDX) announced today that Equine Amnio Solutions – a Texas based veterinary pharmaceutical company, is the grand prize winner of its ninth annual FedEx Small Business Grant Contest. Equine Amnio Solutions (EAS) will receive a $50,000 grant, plus $7,500 in FedEx Office® print and business services to use in the company’s mission to provide innovative products to maximize the health and performance of horses across all breeds and athletic disciplines.

“This has been an extraordinarily tough year on small business owners, which is why it’s so critical that FedEx continues to champion and support these entrepreneurs,” said Jenny Robertson, senior vice president Integrated Marketing and Communications at FedEx. “We love to see small businesses thrive, and we are incredibly proud when we can help play a role in that success.”

The Equine Amnio Solutions story began thanks to the co-founders’ love of horses, via their daughter. Ginger and Ray Johnson are longtime entrepreneurs who brought EAS to market because they have a passion for improving the lives of these animals and the humans who care for them. They plan to use the funds for ongoing clinical studies in tandem with their research and development program to launch a new product for canine use.

“We are honored to be named the 2021 FedEx Small Business Grant Contest Grand Prize Winner,” said Ginger Johnson, Equine Amnio Solutions co-founder. “RenoVō® is an advancement in regenerative medicine for equine use, and we are thrilled at the thought of helping more animals stay healthy.”

FedEx Grant Winner Ginger Johnson
Grand Prize Winner Receives $50,000, plus $7,500 in FedEx Office print services
Equine Amnio Solutions is the market leader in the distribution of next-generation regenerative veterinary products to maximize the health and performance of horses across all breeds and athletic disciplines. One of these products, RenoVō®, has been used in over 4,000 horses and is considered a game-changing equine tissue therapy by owners and veterinarians.

You may want to read these articles

RenoVō® CASE STUDY: Ocular Squamous Cell Carcinoma

RenoVō® CASE STUDY: Ocular Squamous Cell Carcinoma

Case presentation: September 8, 2020: A 10-Year-Old Gelding presented to Milestone Veterinary Care, Backus, MN, with a conjunctival squamous cell carcinoma at the lateral canthus causing visual impairment and destruction of the eye. The attending veterinarian, Fonda...

RenoVō® CASE STUDY: Hoof Injury

RenoVō® CASE STUDY: Hoof Injury

Case presentation: On June 6, 2018, a Long yearling Quarter Horse race horse kicked a weak beam of a stall and torn his left front hoof as he was pulling back. The horse was treated with antibiotics and casted for 2 weeks. The injury persisted and showed sign of...

RenoVō® CASE STUDY: Bilateral Corneal Ulcers

RenoVō® CASE STUDY: Bilateral Corneal Ulcers

August 11, 2020: A horse presented to The Equine Performance Center, Ocala, FL, with bilateral corneal ulcers. Following eye examination, sub-palpebral lavage was placed in both eyes and IV catheter was placed. The horse received aggressive medical therapy including...